Obseva S.A. — 11 Patents, Ranked #51,255

Patents per Year

Showing 1–9 of 9 inventors

Patent	Est. Value	Year
Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists	$9M	2018
Oral formulations of pyrrolidine derivatives	$6M	2018
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same	$5M	2017
Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof	$4M	2020
Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same	$4M	2020